Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: PharmaMar
Relapsed Small Cell Lung Cancer
United States, Australia, Austria, Belgium, Brazil +19 more
- A Phase II Clinical Study to Evaluate the Efficacy and Safety of YKYY018 for Inhalation SolutionNot Yet Recruiting
Sponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Respiratory Syncytial Virus (RSV)
China
Sponsor: Eli Lilly and Company
Lymphoma, Non-Hodgkin's · Lymphoma, Diffuse Large B-Cell · Follicular Lymphoma
United States, France, Germany, Italy, Japan +3 more
Sponsor: Eli Lilly and Company
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
United States, Argentina, Belgium, Bulgaria, Canada +15 more
- Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCActive Not Recruiting
Sponsor: Pfizer
mCRPC
United States, Argentina, Australia, Belgium, Brazil +21 more
Sponsor: AbbVie
Non-Small Cell Lung Cancer
United States, Brazil, China, Israel, Japan +2 more
Sponsor: Boehringer Ingelheim
Focal Segmental Glomerulosclerosis
United States, Argentina, Australia, Belgium, Brazil +35 more
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Brazil +22 more
- Confocal Laser Endomicroscopy Guided Cryobiopsy in the Diagnosis of Interstitial Lung DiseaseCompleted
Sponsor: China-Japan Friendship Hospital
Interstitial Lung Disease (ILD)
China
Sponsor: GlaxoSmithKline
Nasal Polyps
Japan
Sponsor: BioNTech SE
Non-small Cell Lung Cancer
United States, Australia, Belgium, Brazil, Bulgaria +15 more
Sponsor: Osaka University
Aortic Stenosis
Japan
Sponsor: Eli Lilly and Company
Nausea · Vomiting · Drug-Related Side Effects and Adverse Reactions · Neoplasms
United States, Australia, China, France, Italy +5 more
- Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast CancerRecruiting
Sponsor: Novartis Pharmaceuticals
Advanced HR+/HER2- Breast Cancer
United States, Canada, Japan, Singapore, South Korea
- Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid TumorsActive Not Recruiting
Sponsor: Ono Pharmaceutical Co., Ltd.
Advanced or Metastatic Solid Tumors
Japan
Sponsor: Eli Lilly and Company
Elevated Lp(a) · Atherosclerotic Cardiovascular Disease (ASCVD)
United States, Argentina, Australia, Austria, Belgium +23 more
Sponsor: Pfizer
Non-small Cell Carcinoma · Non-Small Cell Lung Cancer Metastatic · Non-Small Cell Lung Carcinoma
United States, Argentina, Australia, Belgium, Brazil +24 more
- A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)Not Yet Recruiting
Sponsor: Pfizer
Obesity
Japan
- Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform StudyActive Not Recruiting
Sponsor: Hoffmann-La Roche
Solid Tumors
United States, Australia, Belgium, Brazil, Canada +18 more
Sponsor: AstraZeneca
Non-small Cell Lung Cancer (NSCLC)
United States, Australia, Austria, Belgium, Brazil +16 more
- Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCActive Not Recruiting
Sponsor: Pfizer
Prostate Cancer
United States, Argentina, Australia, Belgium, Bulgaria +22 more
Sponsor: Pfizer
Eczema
United States, China, Germany, Hungary, Japan +3 more
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Small-cell Lung Cancer
United States, Austria, Belgium, China, Czechia +10 more
- A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet SyndromeCompleted
Sponsor: Takeda
Dravet Syndrome (DS)
United States, Australia, Brazil, Canada, China +13 more
Sponsor: Eli Lilly and Company
Diabetes Mellitus, Type 1
United States, Australia, Belgium, Brazil, Canada +15 more